Oriental Aromatics Ltd. (OAL) AI Stock Analysis

• Market Cap: ₹8.45B
• Dividend Yield: 0.17%
• Average Volume (3M): 819.00
• Price to Earnings (P/E): ―
• Beta (1Y): 0.92
• Revenue Growth: 12.25%
• EPS Growth: -74.52%
• Country: IN
• Employees: 735
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): -0.57
• Shares Outstanding: 33,653,576
• 10 Day Avg. Volume: 1,141
• 30 Day Avg. Volume: 819
• PEG Ratio: 0.10
• Price to Book (P/B): 1.45
• Price to Sales (P/S): 1.04
• P/FCF Ratio: -6.64
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 46 Neutral
• Price Target: ₹238.00 ▼(-17.65% Downside)
• Action: Reiterated Date: 12/09/25
• Date: Action: Reiterated 12/09/25

Oriental Aromatics Ltd. faces significant challenges with bearish technical indicators and a high P/E ratio suggesting overvaluation. Financial performance is mixed, with strong balance sheet metrics but concerning cash flow issues. These factors contribute to a cautious outlook for the stock.

Positive Factors

Conservative leverage / balanced capital structure

A low debt-to-equity ratio (0.53) and a 57.9% equity ratio provide lasting financial flexibility, lower refinancing risk and capacity to absorb cyclical shocks. This durable capital structure supports investment and creditworthiness over the next several months.

Improving return on equity

ROE rising to 5.2% from 1.4% signals better conversion of equity into profits and improved operational effectiveness. Sustained ROE improvement implies management is extracting more value from capital, enhancing long-term shareholder returns if the trend continues.

Net profit margin recovery

Net margin expanding to 3.7% despite revenue pressures indicates effective cost controls or better expense management. Durable margin recovery, if sustained, improves cash generation potential and resilience to revenue volatility, supporting reinvestment and debt service.

Negative Factors

Severe cash flow deterioration

A swing to negative free cash flow of ₹-1,449.33m is a material liquidity deterioration. Persistent negative FCF undermines capacity to fund operations, capex and dividends, may force external financing and raises solvency and operational risk over the medium term.

Compressing gross margins

A drop in gross margin to 14.4% reflects rising input costs or pricing pressure. Margin compression reduces operating leverage, constrains profit resilience and makes earnings more sensitive to revenue swings, requiring structural cost or pricing fixes to restore profitability.

Top-line contraction

An 11.8% revenue decline is a durable warning sign about demand, pricing or market share. Falling sales limit scale benefits, strain fixed-cost absorption and can erode long-term growth prospects unless management reverses the trend through product, market or distribution actions.

Oriental Aromatics Ltd. Business Overview & Revenue Model

Company Description

Oriental Aromatics Limited manufactures and sells terpene chemicals, camphor, and other specialty aroma Ingredients in India. It offers specialty aroma chemicals for use in flavours, fragrances, and essential oils; synthetic camphor for medicinal and religious application; and terpineol, pine oils, astromusk, isobornyl acetate, and terpene resins. The company also provides fragrances for soaps, shampoos, hair oils, detergents, incense sticks, cosmetics and toiletries, household cleaners, air fresheners, etc.; and flavors for instant food, beverages, dairy, confectionery, oral hygiene, sweets, meat, snacks, healthcare, and bakery industries. In addition, it exports its products to Mexico, the United States, Argentina, Brazil, Colombia, France, Geneva, Germany, the Netherlands, Portugal, Spain, Switzerland, Turkey, the United Kingdom, Ukraine, Egypt, Nigeria, Bangladesh, China, Hong Kong, Indonesia, Japan, Malaysia, Myanmar, Oman, Pakistan, Singapore, Sri Lanka, Thailand, the United Arab Emirates, Vietnam, and Yemen. The company was formerly known as Camphor & Allied Products Limited and changed its name to Oriental Aromatics Limited in February 2018. Oriental Aromatics Limited was founded in 1955 and is headquartered in Mumbai, India.

How the Company Makes Money

null

Oriental Aromatics Ltd. Financial Statement Overview

Summary

Oriental Aromatics Ltd. shows mixed financial performance with declining revenue and gross margins, but improved net profitability. The balance sheet remains strong with manageable debt levels and an improving return on equity. However, cash flow issues highlight liquidity risks, necessitating attention to cash management strategies.

Income Statement

Oriental Aromatics Ltd. has experienced fluctuating revenue growth with a decline of 11.8% in 2025 compared to 2024. Gross profit margins have decreased from 18.2% in 2024 to 14.4% in 2025, indicating increased cost pressures. Net profit margin improved from 1.1% to 3.7% in 2025, suggesting better cost management despite lower revenues. EBIT and EBITDA margins have also shown volatility, highlighting potential instability in operational efficiency.

Balance Sheet

The company maintains a relatively low debt-to-equity ratio of 0.53 in 2025, indicating prudent leverage management. Return on equity improved to 5.2% in 2025 from 1.4% in 2024, reflecting enhanced profitability relative to shareholder investments. The equity ratio stands at 57.9%, suggesting a balanced capital structure with moderate reliance on equity financing.

Cash Flow

The cash flow situation is concerning, with a significant decline in free cash flow from a positive position in 2024 (₹424.36 million) to a negative position in 2025 (₹-1,449.33 million). Operating cash flow to net income has turned negative, reflecting cash flow challenges despite profitability improvements. These factors indicate potential liquidity risks and the need for improved cash management.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	9.73B	9.23B	8.36B	8.49B	8.66B	7.09B
Gross Profit	1.69B	1.30B	1.52B	1.62B	1.89B	2.36B
EBITDA	807.24M	966.65M	534.64M	543.09M	969.36M	1.56B
Net Income	98.08M	343.28M	91.04M	197.43M	533.02M	1.02B
Balance Sheet
Total Assets	11.93B	11.45B	9.95B	9.86B	8.65B	7.45B
Cash, Cash Equivalents and Short-Term Investments	50.53M	111.85M	111.76M	181.12M	77.28M	182.48M
Total Debt	3.98B	3.53B	2.06B	2.31B	1.40B	787.02M
Total Liabilities	5.31B	4.82B	3.63B	3.62B	2.60B	1.88B
Stockholders Equity	6.62B	6.63B	6.32B	6.25B	6.05B	5.57B
Cash Flow
Free Cash Flow	-342.96M	-1.45B	424.36M	-689.99M	-603.09M	-176.85M
Operating Cash Flow	-304.21M	-578.94M	1.42B	-223.00M	-8.14M	173.41M
Investing Cash Flow	-38.75M	-865.04M	-989.66M	-464.66M	-594.42M	-349.46M
Financing Cash Flow	258.42M	1.44B	-482.00M	781.48M	514.81M	156.93M

Oriental Aromatics Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 289.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:OAL, the sentiment is Negative. The current price of 289 is above the 20-day moving average (MA) of 262.41, above the 50-day MA of 275.17, and below the 200-day MA of 327.78, indicating a bearish trend. The MACD of -11.04 indicates Positive momentum. The RSI at 35.83 is Neutral, neither overbought nor oversold. The STOCH value of 15.11 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:OAL.

Oriental Aromatics Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
EXCELINDUS	73 Outperform	₹11.06B	34.76	―	1.47%	8.06%	-3.28%
SHREEPUSHK	68 Neutral	₹10.07B	17.66	―	0.52%	28.67%	50.12%
SRHHYPOLTD	63 Neutral	₹7.60B	9.34	―	0.56%	-7.93%	11.44%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
FAIRCHEMOR	47 Neutral	₹6.66B	-2,425.33	―	1.07%	-22.10%	-85.56%
OAL	46 Neutral	₹8.45B	-127.17	―	0.17%	12.25%	-74.52%
VALIANTORG	44 Neutral	₹6.66B	52.56	―	―	16.43%	―